Still no evidence that benzodiazepines cause depression

References

• Smith BD, Salzman C. Do benzodiazepines cause depression?. Hosp Comm Psychiatry 1991; 42: 1101–2
   PubMedGoogle Scholar
• Anonymous. Drugs that may cause psychiatric symptoms. Medical Lett 2002;44.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV-TR). American Psychiatric Association, Washington, DC 2000
   Google Scholar
• Ryan HF, Merril B, Scott GE, Krebs R, Thompson BL. Increase in suicidal thoughts and tendencies. Association with diazepam therapy. J Am Med Assoc 1968; 203: 135–137
   Web of Science ®Google Scholar
• Hall RCW, Joffe JR. Aberrant response to diazepam: a new syndrome. Am J Psychiatry 1972; 129: 114–8
   Web of Science ®Google Scholar
• Hall RCW, Zisook S. Paradoxical reactions to benzodiazepines. Br J Clin Pharm 1981; 11: 99–104S
   PubMed Web of Science ®Google Scholar
• Nathan RG, Robinson D, Cherek DR, Davison S, Sebastian S, Hack M. Long-term benzodiazepine use and depression. Am J Psychiatry 1985; 142: 144–5
   PubMed Web of Science ®Google Scholar
• Lydiard RB, Laraia MT, Ballenger JC, Howell EF. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry 1987; 144: 664–5
   PubMed Web of Science ®Google Scholar
• Lydiard RB, Howell EF, Laraia MT, Fossey M, Ballenger JC. Depression in patients receiving lorazepam for panic. Am J Psychiatry 1989; 146: 1230–1
   PubMed Web of Science ®Google Scholar
• Salas M, Hofman A, Stricker BH. Confounding by indication: An example of variation in the use of epidemiological terminology. Am J Epidemiol 1999; 149: 981–3
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J Am Med Assoc 2003; 289: 3095–105
   PubMed Web of Science ®Google Scholar
• Riemann D, Voderholzer U. Primary insomnia: a risk factor to develop depression?. J Affect Disord 2003; 76: 255–9
   PubMed Web of Science ®Google Scholar
• Lewinsohn PM, Hoberman HM, Rosenbaum M. Prospective study of risk factors for unipolar depression. J Abnorm Psychol 1988; 97: 251–64
   PubMed Web of Science ®Google Scholar
• Craig TJ, van Natta PA. Current medication use and symptoms of depression in a general population. Am J Psychiatry 1978; 135: 1036–9
   PubMed Web of Science ®Google Scholar
• Patten SB, Lavorato DH. Medication use and major depressive syndrome in a community population. Comp Psychiatry 2001; 42: 124–31
   PubMed Web of Science ®Google Scholar
• Patten SB, Barbui C. Drug-induced depression: a systematic review to inform clinical practice. Psychother Psychosom 2004; 73: 207–15
   PubMed Web of Science ®Google Scholar
• Fries ED. Mental depressions in hypertensive patients treated for long periods with large doses of reserpine. New Engl J Med 1954; 251: 1006–8
   PubMed Web of Science ®Google Scholar
• Muller JC, Pryor WW, Gibbons JE, Orgain ES. Depression and anxiety occurring during rauwolfia therapy. J Am Med Assoc 1955; 159: 836–9
   PubMed Web of Science ®Google Scholar
• Lemieux G, Davignon A, Genest J. Depressive states during rauwolfia therapy for arterial hypertension. Can Med Assoc J 1956; 74: 522–6
   PubMedGoogle Scholar
• Fraser HS. Reserpine: A tragic victim of myths, marketing, and fashionable prescribing. Clin Pharm Ther 1996; 60: 368–73
   PubMed Web of Science ®Google Scholar
• Healy D, Savage M. Reserpine exhumed. Br J Psychiatry 1998; 172: 376–8
   PubMed Web of Science ®Google Scholar
• Lavorato DH, Patten SB. Antihypertensive medications and depression, an historical perspective. Pharmacoepidemiol Drug Safety 1999; 8: 355–9
   PubMed Web of Science ®Google Scholar
• Widmer RB. Reserpine: the maligned antihypertensive drug. J Fam Pract 1985; 20: 81–3
   PubMed Web of Science ®Google Scholar
• Nolan BT. Acute suicidal depression associated with use of timolol. J Am Med Assoc 1982; 247: 1567
   Web of Science ®Google Scholar
• Kalayam B, Shamoian CA. Propranolol, psychoneuroendocrine changes, and depression. Am J Psychiatry 1982; 139(10)1374–5
   PubMed Web of Science ®Google Scholar
• McNeil GN, Shaw PK, Dock DS. Substitution of atenolol for propranolol in a case of propranolol-related depression. Am J Psychiatry 1982; 139: 1187–8
   PubMed Web of Science ®Google Scholar
• Russell JW, Schuckit MA. Anxiety and depression in patient on nadolol. Lancet 1982; ii: 1982–3
   Google Scholar
• Oppenheim G. Propranolol-induced depression: mechanism and management. Aust NZ J Psychiatry 1983; 17: 400–2
   PubMed Web of Science ®Google Scholar
• Cremona-Barbaro A. Propranolol and depression. Lancet 1983; i: 185
   Google Scholar
• Pollack MH, Rosenbaum JF, Cassem NH. Propranolol and depression revisited: three cases and a review. J Nerv Ment Dis 1985; 173: 118–9
   PubMed Web of Science ®Google Scholar
• Orlando RG. Clinical depression associated with betaxolol. Am J Ophthalmol 1986; 102: 275
   PubMed Web of Science ®Google Scholar
• Schleifer SJ, Slater WR, Macari-Hinson MM, et al. Digitalis and B-blocking agents: effects on depression following myocardial infarction. Am Heart J 1991; 121(5)1397–402
   PubMed Web of Science ®Google Scholar
• Ried LD, Johnson RE, McFarland BH, Brody KK. Antihypertensive drug use and the risk of depression among older hypertensives in an HMO. J Pharmacoepidemiol 2000; 8: 1–28
   Google Scholar
• Prisant LM, Spruill WJ, Fincham JE, Wade WE, Carr AA, Adams MA. Depression associated with antihypertensive drugs. J Fam Pract 1991; 33: 481–5
   PubMed Web of Science ®Google Scholar
• Stoudemire A, Brown JT, Harris RT, et al. Propranolol and depression: a reevaluation based on a pilot clinical trial. Psychiatric Medicine 1984; 2(2)211–8
   PubMedGoogle Scholar
• Bartels D, Glasser M, Wang A, Swanson P. Association between depression and propranolol use in ambulatory patients. Clin Pharm 1988; 7: 146–50
   PubMedGoogle Scholar
• Carney RM, Rich MW, teVelde A, Saini J, Clark K, Freedland KE. Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications. Am J Med 1987; 83: 223–6
   PubMed Web of Science ®Google Scholar
• Ashton H. Benzodiazepine withdrawal: outcome in 50 patients. Br J Addict 1987; 82: 665–71
   PubMedGoogle Scholar
• Tyrer P, Murphy S, Riley P. The Benzodiazepine Withdrawal Symptom Questionniare. J Affect Disord 1990; 19: 53–61
   PubMed Web of Science ®Google Scholar
• Petty F, Trividi MH, Fulton M, Rush AJ. Benzodiazepines as antidepressants: does GABA play a role in depression?. Biol Psychiatry 1995; 38: 578–91
   PubMed Web of Science ®Google Scholar